Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY6 | Q15077 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | BLM | P54132 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | ITPR1 | Q14643 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA9 | Q16790 | 3/20 | 0.43 |
| ▸ | HTR3A | P46098 | 1/20 | 0.43 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.41 |
| ▸ | GBA1 | P04062 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12418860 | 0.82 | MEN1 (0.67) | P2RY6MEN1BLMKMT2ATHRB | |
| SCHEMBL14049043 | 0.77 | P2RY6 (0.67) | P2RY6MEN1BLMKMT2ATHRB | |
| SCHEMBL10035686 | 0.77 | P2RY6 (0.64) | P2RY6MEN1BLMKMT2ATHRB | |
| SCHEMBL17702684 | 0.77 | P2RY6 (0.64) | P2RY6MEN1BLMKMT2ATHRB | |
| SCHEMBL19767480 | 0.76 | P2RY6 (0.75) | P2RY6MEN1BLMKMT2ATHRB | |
| SCHEMBL15355559 | 0.75 | MEN1 (0.56) | P2RY6MEN1BLMKMT2ATHRB | |
| SCHEMBL18286480 | 0.75 | P2RY6 (0.60) | P2RY6MEN1BLMKMT2ATHRB | |
| SCHEMBL10293759 | 0.75 | P2RY6 (0.64) | P2RY6MEN1BLMKMT2ATHRB | |
| SCHEMBL12418867 | 0.75 | MEN1 (0.67) | P2RY6MEN1BLMKMT2ATHRB | |
| SCHEMBL26441667 | 0.75 | MEN1 (0.67) | P2RY6MEN1BLMKMT2ATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080234221-A1 | Transferring agent into cells; using polypeptides, polynucleotides, antibodies nucleic acids ; tumor suppressor gene; anticancer agents | CANJI, INC. (US) | 2008-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234221-A1 | Transferring agent into cells; using polypeptides, polynucleotides, antibodies nucleic acids ; tumor suppressor gene; anticancer agents | RNASE1, TRDMT1, POLI | P2RY6 2743/4885MEN1 795/4885BLM 2140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.